Decreasing HIV-1 seroprevalence in young adults in a rural Ugandan cohort

書誌事項

公開日
1995-09-30
権利情報
  • http://www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy
DOI
  • 10.1136/bmj.311.7009.833
公開者
BMJ

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p> <jats:bold>Objective</jats:bold> : To assess the trend in HIV-1 seroprevalence in an adult population in Uganda. </jats:p> <jats:p> <jats:bold>Design</jats:bold> : An observational cohort study with four year follow up. </jats:p> <jats:p> <jats:bold>Setting</jats:bold> : A cluster of 15 villages in rural Uganda. </jats:p> <jats:p> <jats:bold>Subjects</jats:bold> : All residents of the 15 villages--about 10000 people. </jats:p> <jats:p> <jats:bold>Main outcome measure</jats:bold> : Prevalence of HIV-1 infection as assessed by enzyme immunoassay. </jats:p> <jats:p> <jats:bold>Results</jats:bold> : During the five year period the overall standardised seroprevalence of HIV-1 showed little change; 8.2% in 1990, 7.6% in 1994. Among males aged 13-24 years the prevalence decreased from 3.4% to 1.0% (P for trend < 0.001); among females of the same age the corresponding values were 9.9% and 7.3%. The decrease was greatest in males aged 20-24 years and females aged 13-19 years. </jats:p> <jats:p> <jats:bold>Conclusion</jats:bold> : This is the first report of a decline in HIV-1 prevalence among young adults in a general population in sub-Saharan Africa with high overall HIV-1 prevalence. It is too early to conclude that the epidemic in this population is in decline, but the results of this study should be reason for some cautious optimism and encourage the vigorous pursuit of AIDS control measures. </jats:p>

収録刊行物

  • BMJ

    BMJ 311 (7009), 833-836, 1995-09-30

    BMJ

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ